Compound Detail
CHEMBL1551
URSODIOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Basic Information
| ChEMBL ID | CHEMBL1551 |
| Name | URSODIOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | RUDATBOHQWOJDD-UZVSRGJWSA-N |
| Therapeutic | ✓ Yes |
7
Targets
17
Activities
3
Assay Types
5
PK Parameters
20
Publications
17
Known Names
20
Indications
1
Mechanisms
Molecular Properties
392.6
MW (Da)
4.48
ALogP
3
HBA
3
HBD
77.8
PSA (Ų)
0.66
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1987 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Bile acid receptor FXR agonist | AGONIST | Bile acid receptor | ✓ | ✓ |
Indications
Liver Cirrhosis, Biliary Liver Cirrhosis, Biliary Cholelithiasis Cholestasis, Intrahepatic Diabetes Mellitus, Type 2 Diabetes, Gestational Hepatitis C, Chronic Liver Diseases Liver Diseases Adenomatous Polyposis Coli Arthritis, Rheumatoid Chemical and Drug Induced Liver Injury Cholangitis, Sclerosing Cholestasis Colorectal Neoplasms Diabetes Mellitus Heart Failure Hepatitis D Inflammation Jaundice, Obstructive
ATC Classification
A05AA02
ursodeoxycholic acid
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: BILE AND LIVER THERAPY
Activity Summary
EC50 10 meas. best 5.62
IC50 4 meas. best 5.58
Ki 3 meas. best 5.95
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDGSH iron-sulfur domain-containing protein 1 CHEMBL1795168 | Ki | 5.95 | 5.95 | 1134.0 | 1 |
| G-protein coupled bile acid receptor 1 CHEMBL5409 | EC50 | 5.62 | 5.03 | 2390.0 | 2 |
| Aminopeptidase N CHEMBL4117 | IC50 | 5.58 | 5.58 | 2600.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.49 | 4.67 | 3270.0 | 7 |
| Hepatic sodium/bile acid cotransporter CHEMBL5287 | IC50 | 5.44 | 5.44 | 3600.0 | 1 |
| Autotaxin CHEMBL3691 | IC50 | 5.03 | 5.03 | 9260.0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 CHEMBL1795168 | IC50 | 4.58 | 4.58 | 26540.0 | 1 |
| Ileal sodium/bile acid cotransporter CHEMBL2778 | Ki | 4.12 | 4.12 | 75000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 2.0 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Rattus norvegicus |
| Tmax | 0.75 | hr | Rattus norvegicus |
| Tmax | 0.75 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine